Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Apr;67(786):347–349. doi: 10.1136/pgmj.67.786.347

A preliminary study of the ocular hypotensive effects of bromocriptine in diabetic patients with autonomic neuropathy.

M R al-Sereiti 1, P Turner 1, E A Gale 1
PMCID: PMC2398792  PMID: 2068026

Abstract

The effect of bromocriptine on intraocular pressure has been investigated in a group of 8 diabetic patients with autonomic neuropathy, to test the hypothesis that bromocriptine exerts its ocular hypotensive action through presynaptic dopamine receptors. Bromocriptine eye drops (0.025%) produced a significant fall in intraocular pressure in a control group of 8 matched normal volunteers, but this effect was not seen in the eyes of the diabetic patients. These results are consistent with a presynaptic site of action of bromocriptine.

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sereiti M. R., Turner P. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP). Br J Clin Pharmacol. 1989 Feb;27(2):159–163. doi: 10.1111/j.1365-2125.1989.tb05346.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ewing D. J., Clarke B. F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):916–918. doi: 10.1136/bmj.285.6346.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Mekki Q. A., Hassan S. M., Turner P. Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet. 1983 Jun 4;1(8336):1250–1251. doi: 10.1016/s0140-6736(83)92699-5. [DOI] [PubMed] [Google Scholar]
  4. Mekki Q. A., Turner P. Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. Br J Ophthalmol. 1985 Dec;69(12):909–910. doi: 10.1136/bjo.69.12.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mekki Q. A., Warrington S. J., Turner P. Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels. Lancet. 1984 Feb 4;1(8371):287–288. doi: 10.1016/s0140-6736(84)90162-4. [DOI] [PubMed] [Google Scholar]
  6. Potter D. E., Burke J. A., Chang F. W. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr Eye Res. 1984 Feb;3(2):307–314. doi: 10.3109/02713688408997214. [DOI] [PubMed] [Google Scholar]
  7. Potter D. E., Burke J. A. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982;2(5):281–288. doi: 10.3109/02713688209000771. [DOI] [PubMed] [Google Scholar]
  8. Shields M. B. The non-contact tonometer. Its value and limitations. Surv Ophthalmol. 1980 Jan-Feb;24(4):211–219. doi: 10.1016/0039-6257(80)90042-9. [DOI] [PubMed] [Google Scholar]
  9. Smith S. A., Dewhirst R. R. A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabet Med. 1986 Jan;3(1):38–41. doi: 10.1111/j.1464-5491.1986.tb00703.x. [DOI] [PubMed] [Google Scholar]
  10. Turner P. Bromocriptine, dopamine and glaucoma. Postgrad Med J. 1986 Sep;62(731):819–820. doi: 10.1136/pgmj.62.731.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. al-Sereiti M. R., Turner P., Gale E. A. Intraocular pressure and pupillary responses in patients with diabetes mellitus. Postgrad Med J. 1991 Mar;67(785):250–251. doi: 10.1136/pgmj.67.785.250. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES